ReviewJournal of medicine and life

The role of novel poly (ADP-ribose) inhibitors in the treatment of locally advanced and metastatic Her-2/neu negative breast cancer with inherited germline BRCA1/2 mutations. A review of the literature.

Lucian Pop et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.